OP Device vs. Bone Autograft for the Treatment of Tibial Nonunions
Not Applicable
Completed
- Conditions
- Tibial Nonunions
- Interventions
- Device: Surgical implantation of OP-1 device or autograft bone graft material
- Registration Number
- NCT00679328
- Lead Sponsor
- Olympus Biotech Corporation
- Brief Summary
This study is to evaluate the safety and effectiveness of the OP device for the treatment of nonunion bone fractures and to compare the healing rates of the OP Device to that of autograft.
- Detailed Description
This study is to evaluate the safety and effectiveness of the OP device for the treatment of nonunion bone fractures and to compare the clinical safety and effectiveness (healing rates) of the OP Device to that of traditional bone autografts to repair nonunions.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 122
Inclusion Criteria
- Patients must show radiographic skeletal maturity
- Documented evidence of previous fracture management
- Nonunion in the tibia and candidate to receive bone autografts and intramedullary (IM) Nail fixation
- Nonunion gap must not exceed half the diameter of the bone at the site of fracture, as assessed radiographically prior to study treatment
Exclusion Criteria
- Patients who do not have adequate vascularity to permit healing
- Patients with inadequate skin coverage
- Patients with chronic use of steroidal medications
- Patients with active infection systemically or at the site of nonunion.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description 1 Surgical implantation of OP-1 device or autograft bone graft material Surgical implantation of OP-1 2 Surgical implantation of OP-1 device or autograft bone graft material Surgical implantation of bone graft material
- Primary Outcome Measures
Name Time Method No further retreatment of the surgical site, function and pain at the site of the nonunion, evidence of bridging. 3, 6, 9, 12, 24 months
- Secondary Outcome Measures
Name Time Method Medical events, treatment related events, laboratory tests, medication use. 3, 6, 9, 12, 24 months